Best Mammography doctors in Israel: TOP 9 doctors

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Dr. Oren Shibolet is a highly experienced gastroenterologist and hematologist with over 50 years of practice. He is a leading expert in liver conditions and treatments, having served as the Head of the Liver Unit at Sourasky (Ichilov) Medical Center. He has a degree in general medicine from the Hebrew University, a specialty in gastroenterology from the Hebrew University Hadassah Medical School, and is a member of multiple medical organizations. He is also an author of over 60 publications and 100 conference reports.

• Education
• 1992-1999 - Faculty of Medicine, Technion.
• Specialization
• 2000-2005 - Internship, Institute of Visualization, Tel Aviv Sourasky Medical Center (Ichilov).
• Recognized experience
• Diagnostic radiology
• Subspecialization:
• 2005-2007 - Breast imaging, Mammography Institute, Tel Aviv Medical Center.
• Additional education
• 2008 - MRI of the mammary gland, internship at the Medical Center of the Curie Institute, Paris, France.
• 2012 - Training period in advanced breast imaging technologies at the Gustave Roussy Cancer Center, Villejuif, France.
• 2009,2011,2013 - Updated courses on breast visualization.
• Clinical experience
• 2013 - Director of the Mammography Department, Tel Aviv Medical Center.
• 2007 - Maccabi HMO Breast Imaging Consultant.
• 2005 - Senior Physician, Sourasky Medical Center, Tel Aviv.
• 2000-2005 - Internship, Institute of Visualization, Sourasky Medical Center, Tel Aviv.
• 1999-2000 - Internship, Sheba Medical Center.
• Academic experience
• 2010- Breast imaging training for medical students in clinical years, Department of Imaging, Faculty of Medicine, Tel Aviv University
• 2013 - Lecturer for surgical interns, School of Continuing Education, School of Medicine, Tel Aviv University.
• 2000-2005 - Lecturer in Visualization at the School of Radiography, Sourasky Medical Center, Tel Aviv, Bar-Ilan University.
• Trade union membership
• Israel Association of Radiologists
• Breast Imaging Department
• Israel Medical Association
• North American Society of Radiology.
• Areas of special interest and activities
• Breast biopsy and preoperative MRI-guided marking.
• Breast visualization in automated 3D ultrasound.
• Removal of breast lumps using non-invasive radiofrequency technology (BLES).
• Mammography with the introduction of a contrast agent.
• Molecular Breast Imaging, MBI (Molecular Breast Imaging)

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Head of the Breast Surgery Department, Mammologist

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.